As of April 24, 2025, TriSalus Life Sciences (TLSI) has a market cap of $0.18 billion USD. According to our data, TriSalus Life Sciences is ranked No.7093 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 24, 2025 | $0.18 B |
20.83%
|
Dec 31, 2024 | $0.15 B |
-40.71%
|
Dec 29, 2023 | $0.26 B |
-15.75%
|
Dec 30, 2022 | $0.31 B |
1.52%
|
Dec 31, 2021 | $0.30 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Bristol-Myers Squibb
BMY
|
$101.37 B |
0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$197.03 B |
-0.050 B
|
![]() USA
|
![]() Pfizer
PFE
|
$127.78 B |
0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$374.44 B |
0.003 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.68 B |
0.124 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.53 B |
-0.004 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$64.01 B |
1.064 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.30 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.26 B |
-0.000 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$744.81 B |
0.006 M
|
![]() USA
|
![]() Novartis
NVS
|
$218.37 B |
1.248 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$126.63 B |
-0.001 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$212.47 B |
0.000 M
|
![]() UK
|
Market Cap | = | TLSI Stock Price | * | TLSI Shares Outstanding |
= | $5.72 | * | 32.27 M | |
= | $0.18 B |